Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone in Suspected Cushing Syndrome
Kannankeril et al.
The finding, in our words
Late-night salivary cortisol was a highly sensitive screen, about 97%, for ACTH-dependent Cushing syndrome, but performed poorly for adrenal disease: a validated screening, not confirmatory, test.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
This study found that salivary 11-dehydrodexamethasone correlates strongly with serum dexamethasone, unlike salivary dexamethasone which shows poor agreement. This validation suggests patients could self-collect saliva samples at home to verify dexamethasone absorption for the overnight suppression test.
This study validated a lateral flow fluorescence assay using quantum dots for saliva and europium nanoparticles for serum to detect cortisol within physiological ranges. The test operates in 15 minutes with a handheld reader, supporting point-of-care and at-home monitoring without a cold chain.
Patient-centric microsampling of salivary cortisol shows a 12.6 nmol/L cutoff at 60 min post cosyntropin stimulation, 89% accuracy, 85% sensitivity and 90% specificity, for adrenal insufficiency diagnosis, but reproducibility in healthy volunteers was poor.
Testosterone, androstenedione, cortisol and cortisone were measurable from 200 µL saliva, but estradiol fell below quantification and progesterone in under half of samples: only a subset of steroids is reliable in saliva, and not interchangeable with serum.
A validated LC-MS/MS assay successfully measured 13 steroid hormones and two synthetic steroids in saliva, requiring only 50 microlitres, or down to 2 to 5 microlitres for nine analytes. This shows saliva's viability for non-invasive, patient-centric microsampling and decentralised monitoring in paediatric, neonatal and adult populations.